Our findings are quite different from those reported by Franco et al. in which SpA patients treated with infliximab or adalimumab had a diminished antibody response whereas RA patients on anti-TNF treatment had as good an immune response as healthy controls [11]. Here, TNF is linked to rheumatoid arthritis.